Community

Advertising Opportunities

 Biotechnology Europe Programs

 Resources

Biotechnology Europe Community

Feedback

Contact

Biotechnology Europe Advantages

Advertising Opportunities on Biotechnology Europe

Sponsorship Opportunities on Biotechnology Europe

 

Post a Job on Biotechnology Europe

Post a Company Profile on Biotechnology Europe

Post a News on Biotechnology Europe

Post an Event on Biotechnology Europe

Post a Product on Biotechnology Europe

Post a Publication on Biotechnology Europe

Post a Technology on Biotechnology Europe

Post a Resume on Biotechnology Europe

Terms of Business

Imprint

Privacy Policy

FAQ

Subscribe Newsletter

 

  BIOTECHNOLOGY EUROPE NEWS    

 

 
 

 
 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

post your news I subscribe newsletter I contact us

 
 

  31.07.2007Amgen Responds to Final CMS National Coverage Determination on Use of Erythropoiesis-Stimulating Agents in Oncology

 
 

  31.07.2007 Cell Therapeutics, Inc. Completes Acquisition of SMi

 
  31.07.2007 Decision About European Marketing Authorization for Oracea® Postponed to 2008
 

31.07.2007MorphoSys Reports Six Months 2007 Results

 

 

30.07.2007 Life Therapeutics Announces New Terms of Agreement with Kedrion 

 

 

30.07.2007 Cell Therapeutics, Inc. Closes $20.25 Million Offering 

 

 

30.07.2007 ACADIA to Host Conference Call and Webcast on Monday, August 6, 2007, at 5:00 p.m. Eastern Time

 

 

26.07.2007 Amgen's Second Quarter 2007 Adjusted Earnings Per Share Increased 7 Percent to $1.12

 

 

26.07.2007 Cell Therapeutics, Inc. Announces $20.25 Million Offering 

 

 

26.07.2007 Pharmion Corporation Reports Net Sales of $65.8 Million for Q2 2007 

 
25.07.2007Oxford Biomedica Announces Data Safety Monitoring Board Recommendation to Continue TROVAX® Phase III Trial in Renal Cancer as Planned
 
25.07.2007 Q2/2007:MerckRevenues Soar 67% to EUR 1.8 Billion
 

25.07.2007Cell Therapeutics, Inc. (CTI) Announces Agreement to Acquire SMi; Gains Global Rights to Brostallicin, in a New Class of Cancer Killing Agents

 
25.07.2007 Bard Announces Second Quarter Results
 
25.07.2007 Invitation to Q2 2007 Conference Call of MorphoSys AG on 30 July 2007
 

19.07.2007Pharmion Corporation to Announce Second Quarter 2007 Financial Results
 

18.07.2007 Merck Transfers Abbott Rights for Niaspan Outside the U.S.
 

18.07.2007 Amgen Completes Acquisition of Ilypsa

 

17.07.2007 Bard to Host Earnings Conference Call on July 24, 2007